Pill Identifier App

Zerenex Approval Status

  • FDA approved: No
  • Brand name: Zerenex
  • Generic name: ferric citrate coordination complex
  • Company: Keryx Biopharmaceuticals, Inc.
  • Treatment for: Hyperphosphatemia of Renal Failure

Zerenex (ferric citrate coordination complex) is a ferric iron-based phosphate binder in development for the treatment of hyperphosphatemia in patients with chronic kidney disease.

FDA Approval Status for Zerenex

May 22, 2014Keryx Receives Notification of PDUFA Date Extension for Zerenex
Oct  8, 2013Keryx Biopharmaceuticals Announces FDA Acceptance for Filing of Zerenex New Drug Application
Aug  8, 2013Keryx Biopharmaceuticals Announces New Drug Application Submission for Zerenex for the Treatment of Hyperphosphatemia in Chronic Kidney Disease Patients on Dialysis

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.